Assessment of Schizophrenia Patients' Clinical Study Experiences

Part of paid clinical trials in San Francisco, California.

Sponsor
Power Life Sciences Inc.
Study ID
NCT05948111
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

The study seeks to delve into the firsthand experiences of patients diagnosed with schizophrenia who partake in a separate clinical trial featuring a specific medical intervention. The primary emphasis will be on meticulously tracking the rates of trial completion and withdrawal among these individuals. The data collected from this study will help improve future outcomes for all schizophrenia patients as well as those in under-represented demographic groups.

Key Dates

Start date
Aug 31, 2024
Status verified
Jul 2023
Primary completion
Aug 31, 2025
Completion
Aug 31, 2026

Study Design

Enrollment
500 participants (estimated)

Primary Outcome Measure

Number of schizophrenia patients who decide to enroll in a clinical trial [ Time Frame: 3 months ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Power Life SciencesSan FranciscoCalifornia94107
Michael B Gill
https://www.withpower.com/[email protected]
415-900-4227

Find similar trials in San Francisco, CA

By condition
Schizophrenia
By specialty
PsychiatryMental healthBehavioral health
By research site
Power Life Sciences· San Francisco, CA

Related Studies